David Braxton, MD discuss catching more patients for biomarker testing

David R. Braxton, MD discusses catching more patients for biomarker testing.

 

Through integrated workflow and advanced analytics, our technology transforms how care teams collaborate; empowering quicker, more precise treatment across all cancer types. Deep Lens is enabling care teams to find the best available clinical trials for a patient’s specific diagnosis—at the time of diagnosis.